High Hampton Holdings Corp Stock Canadian Securities Exchange
Equities
CA42966X2005
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 563K 411K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 841K 614K | Net cash position 2023 | 690K 504K | EV / Sales 2023 | - |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
-8.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.53% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 23-09-25 |
Director of Finance/CFO | 54 | 23-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 54 | 23-09-18 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 23-09-25 |
Anderson Shannon
BRD | Director/Board Member | - | 23-09-18 |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |